Anastrozole and Fulvestrant Compared to Anastrozole as Adjuvant Treatment of Postmenopausal Patients With Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Breast Cancer
Interventions
DRUG

Fulvestrant

intramuscular injection

DRUG

Anastrozole

1 mg oral tablet

Trial Locations (25)

Unknown

Research Site, Feldkirch

Research Site, Graz

Research Site, Innsbruck

Research Site, Klagenfurt

Research Site, Leoben

Research Site, Linz

Research Site, Salzburg

Research Site, Sankt Veit im Pongau

Research Site, Vienna

Research Site, Wiener Neustadt

Research Site, Bayreuth

Research Site, Essen

Research Site, Hamburg-Eppendorf

Research Site, Heidelberg

Research Site, Munich

Research Site, Rostock

Research Site, Tübingen

Research Site, Drammen

Research Site, Fredrikstad

Research Site, Kristiansand

Research Site, Oslo

Research SIte, Porsgrunn

Research Site, Stavanger

Research Site, Trondheim

Research Site, Tønsberg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY